Long-term sustained effect of biological psoriasis treatment

ScienceDaily | 6/28/2017 | Staff
shuadah (Posted by) Level 3
"We employed a real-life patient perspective in this study," says Marcus Schmitt-Egenolf, professor at the Department of Public Health and Clinical Medicine at Umeå University and senior author of the study.

"Most studies in this area were initiated by the industry and conducted in controlled settings that are ultimately beneficial for their product. Consequently, those studies cannot really predict how a product will perform under real-life circumstances, with real-life patients."

Study - Data - Consultations - Patients - Psoriasis

The current study was based on data from repeated consultations of patients included in the Swedish psoriasis register and conducted by researchers at Umeå University and the Swedish Institute for Health Economics (IHE) in Lund.

Psoriasis is a common autoimmune skin disease affecting about three percent of the western population. Moderate-to-severe psoriasis is associated with a dose-dependent risk for cardiovascular and metabolic morbidity. In the beginning of the century, the introduction of a new class of drugs for psoriasis, biologics, transformed the treatment of moderate-to-severe psoriasis by providing better skin clearance rates, low toxicity, and improved quality-of-life. This study, following real-life patients for...
(Excerpt) Read more at: ScienceDaily
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!